You are viewing: UK Radiotherapy Market analysis
Part of: Radiotherapy Market (Global)

The UK Radiotherapy Market was valued at $423.1 Million in 2026 and projected to reach to $541.3 Million by 2031, representing a compound annual growth rate of 5.1%. The UK radiotherapy market is positioned for sustained growth through 2031, driven by demographic shifts, technological advancement, and NHS investment in cancer care infrastructure.

UK Radiotherapy Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Radiotherapy Market Trends and Insights

  • The UK's radiotherapy sector is supported by a well-established National Health Service infrastructure, increasing cancer incidence rates, and rising demand for advanced treatment modalities.
  • The UK market benefits from strong regulatory frameworks and investment in oncology centers across England, Scotland, Wales, and Northern Ireland. Key drivers of growth in the UK radiotherapy market include an aging population with higher cancer prevalence, technological advancements in treatment delivery systems, and increased adoption of precision medicine approaches.
  • The UK's commitment to cancer care through NHS initiatives and the expansion of radiotherapy capacity in underserved regions are accelerating market expansion.
  • Between 2026 and 2031, the UK radiotherapy market will experience steady growth as healthcare providers modernize equipment and expand treatment accessibility. The UK radiotherapy landscape is characterized by a mix of public NHS facilities and private treatment centers, with growing emphasis on personalized cancer care.
  • Market consolidation and partnerships among UK healthcare providers are expected to enhance service delivery and patient outcomes throughout the forecast period..

Key Market Statistics

  • CAGR (2026-2031) 5.1% CAGR
  • Market Size, 2026 ~USD 423.1 Million
  • Forecast, 2031 ~USD 541.3 Million
  • Country UK

UK Radiotherapy Market Overview

Market Valuation :

The UK radiotherapy market is valued at £423.1 million in 2026 and is projected to reach £541.3 million by 2031, representing steady growth in the healthcare sector.

NHS Infrastructure Advantage :

The UK's well-established National Health Service provides a robust framework for radiotherapy delivery, ensuring consistent funding, standardized protocols, and widespread access across the nation.

Rising Cancer Incidence :

Increasing cancer diagnosis rates in the UK are driving demand for advanced radiotherapy treatments, with an aging population contributing to higher treatment volumes and market expansion.

Advanced Treatment Adoption :

UK healthcare providers are increasingly adopting cutting-edge radiotherapy modalities including intensity-modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT) technologies.

UK Radiotherapy Market Dynamics

  • The 5.1% CAGR reflects steady demand for radiotherapy services as cancer prevalence continues to rise among the UK population.
  • Healthcare providers are modernizing treatment facilities and integrating AI-powered planning systems to improve patient outcomes.
  • Regulatory support and clinical evidence backing advanced radiotherapy techniques further strengthen market momentum.
  • The market will benefit from increased collaboration between NHS trusts and private providers, expanding treatment capacity and accessibility across regions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK radiotherapy market will grow from £423.1M (2026) to £541.3M (2031) at a 5.1% CAGR.
    • The UK's aging population and rising cancer incidence are primary growth catalysts for radiotherapy demand.
    • NHS infrastructure and regulatory support position the UK as a mature, stable radiotherapy market within Europe.
    • Technological innovation and precision medicine adoption are reshaping treatment delivery across UK oncology centers.

    Radiotherapy Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment SYNCHROTRONS (System Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6% from 2026 to 2031
    Largest Segment EXTERNAL BEAM RADIOTHERAPY (Application)
    Market Size Base Year (Billions) ~USD 7.98 (2026)
    Revenue Forecast (Billions) ~USD 10.68 (2031)
    Segments Covered System And Software & Service 2024–2031, Application, Type, Procedure, Technology, System Type, End User, System And Software & Service

    UK Radiotherapy Market Report Segmentation

    8 segment dimensions are covered across the global market.

    By System And Software & Service 2024–2031

    • Software & Services
    • Systems

    By Application

    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/Brachytherapy

    By Type

    • 3D Conformal Radiotherapy
    • Afterloaders
    • Applicators
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • Conventional Co
    • Conventional Cobalt-60 Teletherapy
    • Conventional Linacs
    • Cyberknife
    • Gamma Knife
    • Gynecological Cancer
    • Hdr Brachytherapy
    • Head & Neck Cancer
    • Image-Guided Radiotherapy
    • Intensity-Modulated Radiotherapy
    • Iort Systems
    • Ldr Brachytherapy
    • Linac
    • Linacs
    • Lung Cancer
    • Mri Linacs
    • Other Ebrt Applications
    • Other Ebrt Procedures
    • Other External Beam Radiotherapy Applications
    • Other External Beam Radiotherapy Procedures
    • Other Ibrt Applications
    • Other Internal Beam Radiotherapy/
    • Particle Therapy
    • Pdr Brachytherapy
    • Penile Cancer
    • Prostate Cancer
    • Seeds
    • Stereotactic Advanced Electron/Cobalt-60 Linacs
    • Stereotactic Therapy
    • Tomotherapy

    By Procedure

    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/ Brachytherapy

    By Technology

    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/ Brachytherapy
    • Internal Beam Radiotherapy/Brachytherapy

    By System Type

    • Cyclotrons
    • Synchrocyclotrons
    • Synchrotrons

    By End User

    • Hospitals
    • Independent Radiotherapy Centers

    By System And Software & Service

    • Software & Services
    • Systems

    Target Audience

    • Medical Device Manufacturers : Equipment and technology providers need UK-specific market data to develop localized sales strategies, understand NHS procurement cycles, and identify partnership opportunities with healthcare trusts.
    • Healthcare Consultants : Strategy and management consultants require detailed UK market analysis to advise NHS trusts, private providers, and investors on radiotherapy service expansion and modernization initiatives.
    • Investment & Private Equity Firms : Investors evaluating UK healthcare opportunities need comprehensive market sizing, growth projections, and competitive intelligence to assess radiotherapy sector investments and acquisition targets.
    • NHS Trust Leadership : Hospital administrators and clinical directors need market insights to justify capital investments in radiotherapy infrastructure, benchmark performance against peers, and plan service development.
    • Pharmaceutical & Biotech Companies : Organizations developing cancer therapeutics require UK radiotherapy market data to understand treatment patterns, identify combination therapy opportunities, and plan clinical trial strategies.

    Key Companies in the UK Radiotherapy Market

    CompanyHQOwnershipStrongest segments
    ADVANCED MEDICAL ISOTOPE CORPORATIONUnited StatesPublic CompanyIsoPet (veterinary radionuclide therapy),RadioGel and human oncology platforms,PLGA-g-PEG and PrecisionGel polymer platforms,
    UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
    BECTON DICKINSON AND COUnited StatesPublic CompanyMedical Essentials (syringes, needles, catheters, IV sets, sharps disposal),Connected Care & Medication Management (infusion, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    UNITED IMAGING HEALTHCARE CO., LTD.ChinaPublic CompanyCT and MRI systems,Molecular imaging (PET/CT, SPECT),Radiotherapy systems (uRT-linac and ecosystem),
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
    SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
    ELEKTASwedenPublic CompanyLinear accelerators and MR-Linac (Unity, Evo, Versa HD, Harmony, Infinity),Stereotactic radiosurgery (Elekta Esprit gamma knife and neurosurgery systems),Brachytherapy solutions (Elekta Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, Xoft Axxent),
    ACCURAY INCORPORATEDUnited StatesPublic CompanyCyberKnife platform (systems + upgrades + related services),TomoTherapy / Radixact platform (systems + upgrades + related services),Software & data management (iDMS, Accuray Precision, other planning/data tools),
    HITACHI HIGH-TECH CORPORATIONJapanPrivate CompanyAnalytical & Medical Solutions (microscopes, clinical analyzers, chromatography, spectroscopy),Nano-Technology Solutions (dry etch, CD-SEM, wafer inspection, FIB),Industrial Solutions and ICT (industrial infrastructure, energy, control systems, ICT/IoT),
    SUMITOMO HEAVY INDUSTRIES, LTD.JapanPublic CompanyMechatronics (gearmotors, drives, precision positioning, cryogenic equipment),Industrial Machinery (plastics, film forming, semiconductor, medical, defense),Logistics & Construction (excavators, cranes, road and logistics systems),
    MEVION MEDICAL SYSTEMSUnited StatesPrivate CompanyMevion S250i with Hyperscan and Adaptive Aperture,Mevion S250 series (base compact systems),Mevion S250MX multi-room solution,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy (systems and devices),Connected Care & Monitoring (incl. enterprise informatics),
    SHINVA MEDICAL INSTRUMENT CO., LTD.ChinaPublic CompanyMedical Device Products (infection control, OR integration, radiotherapy, surgical instruments, IVD, dialysis, orthopedic implants),Pharmaceutical Equipment Products (large/small volume injection lines, BFS, freeze dryers, aseptic systems),Medical Trade Products,

    ADVANCED MEDICAL ISOTOPE CORPORATION

    Advanced Medical Isotope Corporation is a publicly traded company established in 1994 that operates in the medical isotope sector in the United States.

    UNILABS

    Unilabs is a Swiss private company founded in 1987 with 1,897 employees providing laboratory and diagnostic services.

    BECTON DICKINSON AND CO

    Becton Dickinson and Co is a publicly traded medical technology company founded in 1897 with 72,000 employees, headquartered in the United States.

    UNITED IMAGING HEALTHCARE CO., LTD.

    United Imaging Healthcare Co., Ltd. is a Chinese public company founded in 2011 with 8,703 employees specializing in medical imaging technology.

    GE HEALTHCARE

    GE Healthcare is a publicly traded healthcare company established in 2022 with 54,000 employees based in the United States.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees operating in the healthcare technology sector.

    ELEKTA

    Elekta is a Swedish public company founded in 1972 with 3,704 employees specializing in radiation therapy and radiosurgery solutions.

    ACCURAY INCORPORATED

    Accuray Incorporated is a publicly traded medical device company founded in 1990 with 990 employees based in the United States.

    HITACHI HIGH-TECH CORPORATION

    Hitachi High-Tech Corporation is a Japanese private company founded in 1947 with 11,482 employees providing advanced technology solutions.

    SUMITOMO HEAVY INDUSTRIES, LTD.

    Sumitomo Heavy Industries, Ltd. is a Japanese public company founded in 1888 with 25,123 employees operating across multiple industrial sectors.

    MEVION MEDICAL SYSTEMS

    Mevion Medical Systems is a private medical device company established in 2004 with 165 employees operating in the United States.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees operating in healthcare, consumer, and industrial sectors.

    SHINVA MEDICAL INSTRUMENT CO., LTD.

    Shinva Medical Instrument Co., Ltd. is a Chinese public company founded in 1943 with 7,982 employees specializing in medical instruments.

    Reasons to Buy this Report

    • NHS Market Intelligence : Gain detailed insights into NHS procurement patterns, funding allocations, and strategic priorities shaping the UK radiotherapy landscape through 2031.
    • Regional Growth Opportunities : Identify high-growth regions within the UK where radiotherapy infrastructure investment is accelerating and treatment demand is outpacing current capacity.
    • Competitive Positioning : Benchmark your organization against UK market leaders, understand competitive dynamics, and identify white-space opportunities in underserved treatment segments.
    • Technology Adoption Trends : Track adoption rates of advanced radiotherapy modalities across UK healthcare systems, informing product development and market entry strategies.
    • Regulatory & Reimbursement Landscape : Understand UK regulatory requirements, NICE guidance, and NHS reimbursement frameworks essential for successful market participation and pricing strategies.

    Frequently asked questions

    What is the current size of the UK radiotherapy market?

    The UK radiotherapy market is valued at £423.1 million in 2026 and is expected to reach £541.3 million by 2031.

    What is the growth rate of the UK radiotherapy market?

    The UK radiotherapy market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2031.

    What factors are driving growth in the UK radiotherapy market?

    Key growth drivers include an aging population, rising cancer incidence, technological advancements in treatment delivery, NHS investment in oncology infrastructure, and increased adoption of precision medicine approaches.

    How is the UK radiotherapy market structured?

    The UK radiotherapy market comprises both public NHS facilities and private treatment centers, with increasing emphasis on integrated care pathways and personalized cancer treatment.

    What is the forecast market size for UK radiotherapy in 2031?

    The UK radiotherapy market is forecast to reach £541.3 million by 2031, representing a £118.2 million increase from the 2026 baseline.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the radiotherapy market's segments and subsegments. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    The market for companies offering radiotherapy products is derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem and rating them by performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. Secondary research was used to obtain critical information on the industry's value chain, the total pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.

    In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data regulation methods, to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted across the entire market engineering process to identify key insights throughout the report.

    A breakdown of the primary respondents is provided below:

    Radiotherapy Market
 Size, and Share

    Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various market segments.

    To determine the size of the global radiotherapy market, revenue share analysis was employed with the leading players. In this case, key market players have been identified, and their radiotherapy product business revenues have been determined using insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research included in-depth interviews with key opinion leaders, particularly chief executive officers, directors, and key marketing executives.

    Radiotherapy Market : Top-Down and Bottom-Up Approach

    Radiotherapy Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size through the market size estimation process described above, the global radiotherapy market was segmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.

    Market Definition

    The radiotherapy market includes a range of products, solutions, technologies, and services that utilize high-energy radiation for therapeutic purposes. This encompasses various types of radiation, such as X-ray, gamma, electron, and particle radiation. The technologies segment of radiotherapy features systems designed to treat diseases, primarily cancer. This includes external beam radiotherapy methods like LINAC, MRI-LINAC, and cobalt-60 teletherapy. Additionally, internal radiotherapy solutions, commonly known as brachytherapy, are also part of this market segment. Other components of the radiotherapy market include software for imaging and treatment planning. Furthermore, the market provides maintenance and training services related to radiotherapy technologies.

    Key Stakeholders

    • Radiotherapy product manufacturing companies
    • Distributors, suppliers, and commercial service providers
    • Healthcare service providers
    • Clinical research organizations (CROs)
    • Radiotherapy service providers
    • Radiotherapy product distributors
    • Medical research laboratories
    • Cancer care centers
    • Cancer research organizations
    • Academic medical centers and universities
    • Market research and consulting firms

    Report Objectives

    • To define, describe, and forecast the radiotherapy market based on offering, technology, application, procedure, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global radiotherapy market (drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets for individual growth trends, prospects, and contributions to the global radiotherapy market
    • To analyze key growth opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Arica)
    • To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
    • To track and analyze the competitive developments undertaken in the global radiotherapy market, such as agreements, expansions, and product launches

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top 16 companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to 15)

    Geographic Analysis

    • Further breakdown of the Rest of Europe radiotherapy market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific radiotherapy market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries
    • Further breakdown of the Rest of Latin America radiotherapy market into Argentina, Chile, Peru, and Colombia, among others

    Get the Full Radiotherapy Market Report

    Full forecast, segment splits, and company analysis for all Radiotherapy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status